Long-term follow-up study of three patients with the long QT syndrome.
We studied three women with the long QT syndrome. They were aged 42, 52 and 25 years and had experienced recurrent syncopal attacks. We followed case 1 for 17, case 2 for 18, and case 3 for over 6 y. The attacks tended to occur during the premenstrual stage in case 1 and case 2; case 3 often experienced attacks after exercise. The QT(U)c intervals on admission were 0.68, 0.62, and 0.50 in case 1, 2, and 3, respectively. Torsade de pointes followed by ventricular fibrillation was documented in case 1 and case 2. Although each was treated with a beta-blocker, none was fully compliant with the regimen. In case 1, estrogen therapy administered to maintain the hormonal balance premenstrually effectively prevented attacks. Despite the inconsistent use of beta-blockers, the attacks in case 1 and case 2 tended to decrease with age. Case 2 experienced no attacks after menopause. Cause 3 took medication consistently and remained free of attacks for over 6 y. Although she discontinued beta-blocker therapy because of pregnancy, she has experienced no attacks to date. These case studies suggest that hormonal status may be important in the development of syncopal attacks in female patients with the long QT syndrome.
Nakazato
Y
Y
Department of Cardiology, Juntendo University School of Medicine, Tokyo, Japan.
Nakata
Y
Y
Tokano
T
T
Ohno
Y
Y
Fujioka
H
H
Hisaoka
T
T
Sumiyoshi
M
M
Ogura
S
S
Sakurai
H
H
Yamaguchi
H
H
D000328:Adult; D004562:Electrocardiography; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008133:Long QT Syndrome / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology*; D008875:Middle Aged; D010869:Pindolol / Q000627:therapeutic use; D011379:Prognosis; D013575:Syncope / Q000209:etiology; D013997:Time Factors
D004967:Estrogens; D010869:Pindolol